You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

Drug Price Trends for NDC 50268-0198


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 50268-0198

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
CAPSAICIN 0.1% CREAM,TOP AvKare, LLC 50268-0198-42 42.5GM 7.74 0.18212 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for Drug NDC: 50268-0198

The pharmaceutical industry is constantly evolving, with new drugs entering the market and existing ones facing price fluctuations. One such drug that has garnered attention is NDC: 50268-0198. This article delves into the market analysis and price projections for this specific drug, providing insights for healthcare professionals, policymakers, and investors alike.

Understanding NDC: 50268-0198

NDC: 50268-0198 is a unique identifier for a specific drug product. The National Drug Code (NDC) is a universal product identifier for human drugs in the United States[5]. This particular NDC belongs to a drug that has been registered with the FDA and is currently in commercial distribution.

Current Market Position

As of 2025, the pharmaceutical market is experiencing significant growth and transformation. The global biotech market is projected to expand from $483.0 billion in 2024 to $546.0 billion by 2025, reflecting a robust compound annual growth rate (CAGR) of approximately 13%[7]. Within this expanding market, NDC: 50268-0198 has carved out its own niche.

Pricing Trends

The pricing of prescription drugs, including NDC: 50268-0198, is influenced by various factors. According to a GAO report, drug manufacturers consider several elements when setting prices for brand-name prescription drugs, including a drug's patent status[8].

From 2000 to 2008, 416 brand-name drug products—different drug strengths and dosage forms of the same drug brands—had extraordinary price increases. These 416 brand-name drug products represented 321 different drug brands[8].

This historical data suggests that significant price fluctuations are not uncommon in the pharmaceutical industry, and NDC: 50268-0198 may experience similar trends.

Factors Influencing Price Projections

Several factors are likely to influence the price projections for NDC: 50268-0198:

1. Patent Status

The patent status of a drug significantly impacts its pricing. If NDC: 50268-0198 is a brand-name drug with patent protection, it may maintain higher prices. However, as patents expire, generic competition can lead to price reductions.

2. Market Demand

The demand for the drug in the market plays a crucial role in determining its price. If NDC: 50268-0198 treats a condition with a growing patient population, it may see sustained or increased demand, potentially supporting higher prices.

3. Production Costs

Changes in production costs, including raw material prices and manufacturing processes, can impact the drug's pricing. Any significant changes in these costs for NDC: 50268-0198 will likely be reflected in its market price.

4. Regulatory Environment

The regulatory landscape, including policies on drug pricing and reimbursement, can significantly influence price projections. For instance, the recent political shifts in the U.S. may lead to changes in healthcare regulations that could affect drug pricing[7].

Market Competition

The competitive landscape for NDC: 50268-0198 is an essential factor in its price projections. The presence of similar drugs or potential new entrants in the market can exert downward pressure on prices.

Reimbursement Policies

Insurance coverage and reimbursement policies play a crucial role in determining the effective price of drugs for consumers. Changes in these policies can significantly impact the market position and pricing of NDC: 50268-0198.

Technological Advancements

Advancements in drug development and manufacturing technologies can influence production costs and, consequently, pricing. Any technological breakthroughs relevant to NDC: 50268-0198 could impact its future pricing.

Global Market Dynamics

While NDC: 50268-0198 is a U.S.-specific identifier, global market dynamics can still influence its pricing. International demand, exchange rates, and global economic conditions all play a role in shaping pharmaceutical markets.

Future Price Projections

Based on the current market trends and factors influencing drug pricing, we can make some projections for NDC: 50268-0198:

Short-term Projections (1-2 years)

In the short term, the price of NDC: 50268-0198 is likely to remain relatively stable, barring any significant market disruptions or regulatory changes. The ongoing growth in the pharmaceutical sector suggests a favorable environment for maintaining current pricing levels.

Medium-term Projections (3-5 years)

In the medium term, we may see more significant price fluctuations. Factors such as patent expiration (if applicable), new market entrants, or changes in production costs could lead to price adjustments. The direction of these adjustments will depend on the specific circumstances of NDC: 50268-0198.

Long-term Projections (5+ years)

Long-term price projections are more uncertain and will heavily depend on factors such as technological advancements, changes in market demand, and evolving regulatory landscapes. However, the overall trend in the pharmaceutical industry suggests continued growth, which could support stable or increasing prices for successful drugs.

Impact of Political Changes

The recent political shifts in the U.S., particularly the appointment of Robert F. Kennedy Jr. as the head of the Department of Health and Human Services (HHS), could have significant implications for the pharmaceutical industry[7]. These changes may lead to new policies affecting drug pricing, potentially impacting the future price of NDC: 50268-0198.

Role of Medicare Drug Price Negotiation Program

The Medicare Drug Price Negotiation Program, set to begin in January 2026, could have a substantial impact on drug pricing, including NDC: 50268-0198 if it falls under the program's purview[2].

Beginning in January 2026, the first 10 negotiated prices are slated to go into effect in Medicare Part D. Nine of the 10 drugs selected for the first year of negotiation had list price increases of 20 to 55 percent between 2018 and 2023, while the list price for one drug declined by 1 percent[2].

This program aims to address the issue of high prescription drug prices in the United States, which could lead to more controlled pricing for certain drugs.

Market Opportunities

Despite potential pricing pressures, the pharmaceutical market continues to offer significant opportunities. The immunology market, for instance, is projected to grow from $103.18 billion in 2024 to $257.39 billion by 2032[7]. If NDC: 50268-0198 is related to this or other growing therapeutic areas, it may benefit from increased market demand.

Challenges in Price Projections

Projecting drug prices accurately presents several challenges:

  1. Market Volatility: The pharmaceutical market can be volatile, with prices subject to sudden changes due to various factors.

  2. Regulatory Uncertainty: Changes in healthcare policies and regulations can significantly impact drug pricing.

  3. Technological Disruptions: Breakthroughs in drug development or manufacturing could alter the competitive landscape.

  4. Global Events: Unforeseen global events, such as pandemics or economic crises, can disrupt market projections.

Strategies for Stakeholders

Given the complex nature of drug pricing and market dynamics, stakeholders involved with NDC: 50268-0198 should consider the following strategies:

  1. Continuous Monitoring: Keep a close eye on market trends, regulatory changes, and technological advancements that could impact pricing.

  2. Flexibility: Maintain flexibility in pricing strategies to adapt to changing market conditions.

  3. Innovation: Invest in research and development to enhance the drug's value proposition and maintain market competitiveness.

  4. Stakeholder Engagement: Engage with policymakers, healthcare providers, and patient groups to understand and address concerns related to drug pricing.

  5. Transparency: Maintain transparency in pricing decisions to build trust with consumers and regulators.

Future Outlook

The future of NDC: 50268-0198 in the market will depend on a complex interplay of factors, including its therapeutic value, market demand, competitive landscape, and regulatory environment. While precise long-term price projections are challenging, the overall growth trend in the pharmaceutical industry suggests a potentially favorable environment for drugs that can demonstrate clear value and meet unmet medical needs.

Key Takeaways

  • NDC: 50268-0198 is a unique identifier for a specific drug product in the U.S. market.
  • The global biotech market is projected to grow significantly, reaching $546.0 billion by 2025.
  • Drug pricing is influenced by factors such as patent status, market demand, production costs, and regulatory environment.
  • The Medicare Drug Price Negotiation Program, set to begin in 2026, could impact drug pricing.
  • Political changes, including new appointments in the Department of Health and Human Services, may lead to policy shifts affecting drug pricing.
  • Stakeholders should maintain flexibility, invest in innovation, and engage with various stakeholders to navigate the complex pharmaceutical market.
  • While precise long-term price projections are challenging, the growing pharmaceutical market offers opportunities for drugs that demonstrate clear value.

FAQs

  1. What is an NDC number? An NDC (National Drug Code) number is a unique, three-segment number assigned by the FDA to human drugs in the United States. It identifies the labeler, product, and trade package size.

  2. How often do drug prices typically change? Drug prices can change frequently, with some experiencing multiple price adjustments per year. However, the frequency and magnitude of changes vary widely among different drugs and manufacturers.

  3. Can international markets affect the pricing of a drug with a U.S.-specific NDC? Yes, while the NDC is specific to the U.S. market, global market dynamics, including international demand and economic conditions, can influence a drug's pricing strategy even within the U.S.

  4. How might the Medicare Drug Price Negotiation Program affect drug pricing? The program aims to negotiate prices for certain high-cost drugs covered by Medicare, potentially leading to lower prices for these drugs. This could have ripple effects across the pharmaceutical market.

  5. What role does patent status play in drug pricing? Patent status significantly influences drug pricing. Drugs under patent protection often maintain higher prices due to lack of competition. Once patents expire and generic versions enter the market, prices typically decrease.

Sources cited: [2] https://aspe.hhs.gov/sites/default/files/documents/3e8abec86039ac0ed674a8c5fac492e3/price-change-over-time-brief.pdf [5] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information [7] https://www.labiotech.eu/in-depth/biotech-trends-2025/ [8] https://www.gao.gov/assets/gao-10-201.pdf

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.